Markets & Investing
How Can I Get Involved in the Psychedelics Industry?: Mindshifting Moments #20
On this edition of Mindshifting Moments, Margaret Williamson is joined by Logan Lenz, the CEO of Nucleus. During this conversation, the two talk about…
On this edition of Mindshifting Moments, Margaret Williamson is joined by Logan Lenz, the CEO of Nucleus. During this conversation, the two talk about how the psychedelics industry is being built to be more accessible and overview the ways anyone can participate in the growing industry.
More About Nucleus
Nucleus was founded in mid-2021 after Neuly and Psychedelic Invest were purchased by Iter Investments, a prominent venture capital firm investing in the psychedelics industry. In late 2021, the official team was constructed, and Nucleus launched in January 2022 with the mission of connecting people with the psychedelics industry in order to propel psychedelic-assisted therapy forward. Nucleus strives to accomplish this mission by serving the industry as a venture studio building brands that educate the masses, activate new stakeholders, and distribute data about these powerful medicines.
Transcription
The transcription will be available after the event.
-
Psychedelics1 week ago
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support
-
Law & Regulation1 week ago
FDA to weigh safety, impact of MDMA therapy for PTSD at June meeting
-
Psychedelics1 week ago
MindMed Reports First Quarter 2024 Financial Results and Business Updates
-
Psychedelics1 week ago
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University’s Institute for Psychedelic Research
-
Psilocybin1 week ago
Oregon authorities give Kaya Holdings license for psilocybin treatment clinic
-
Law & Regulation1 week ago
Compass Pathways keeps plugging away with its psilocybin study trials
-
Ketamine1 week ago
Clinical-Stage BioTech Drug Stocks Portfolio UP 7% In w/e May 3rd
-
Psychedelics1 week ago
Optimi Health Provides Corporate Update